Home › Novogen Announces Breakthrough Discovery In The Treatment Of Melanoma
 

Keywords :   


Novogen Announces Breakthrough Discovery In The Treatment Of Melanoma

2014-12-29 02:07:31| drugdiscoveryonline Home Page

Novogen Limited (ASX:NRT; NASDAQ: NVGN), Australian/US biotechnology company, today announces that it has confirmed that its lead candidate product, TRXE-009, originally developed for the treatment of brain cancers, has been shown in pre-clinical studies also to be highly active against melanoma

Tags: treatment discovery announces breakthrough

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
05.10Weekly Recap: BASF, Beckers, Allnex, Sherwin-Williams Top This Weeks Stories
05.10Hurricane Kirk Graphics
05.10Hurricane Kirk Forecast Discussion Number 24
05.10Hurricane Kirk Wind Speed Probabilities Number 24
05.10Hurricane Kirk Forecast Advisory Number 24
05.10Hurricane Kirk Public Advisory Number 24
05.10Summary for Hurricane Kirk (AT2/AL122024)
05.10Hurricane Leslie Graphics
More »